Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Duke Realty Limited Partnership, an operating partner of real estate investment trust (REIT) Duke Realty Corporation ( DRE - Analyst Report ) , has recently priced $300 million of 4.375% senior unsecured notes due June 15, 2022 in an underwritten public offering.The notes are priced at 99.271% of the face amount to yield 4.466% at maturity.The offering is expected to close on June 11, 2012.
Net proceeds from the debt offer will be used to repay debt including all or a portion of outstanding borrowings under the operating partnership's existing revolving credit facility, and for other general corporate purposes.
During the first quarter of 2012, the company issued 10.8 million new shares of common stock generating net proceeds of approximately $147 million to increase liquidity.
Duke Realty maintains a balanced and flexible balance sheet with ample liquidity and minimal debt maturities that enable it to capitalize on potential acquisition opportunities to fuel its top-line growth.
At the end of first quarter 2012, the company had nearly $15.0 million of cash with no outstanding debt on its line of credit. The total-debt-to-undepreciated-assets covenant was 49.25% at quarter end, while the debt service coverage ratio was 2.19x.
Headquartered in Indianapolis, Duke Realty is engaged in owning, managing and developing industrial, healthcare and office properties across the U.S.For over 35 years, the company has leveraged its local presence and its integrated platform to drive returns, and has established itself as a premier publicly traded real estate developer in the country.
Duke Realty currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We maintain our long-term Neutral recommendation on the stock. One of its competitors, Highwoods Properties Inc. ( HIW - Analyst Report ) , also holds a Zacks #3 Rank.
Read the full reports :
Analyst Report on DRE
Analyst Report on HIW